| scholarly article | Q13442814 |
| P50 | author | Kari Hemminki | Q63213683 |
| Mahdi Fallah | Q51251037 | ||
| Donna Ankerst | Q58241772 | ||
| P2093 | author name string | Ian M Thompson | |
| Robin J Leach | |||
| Stephen Freedland | |||
| Sonja Grill | |||
| P2860 | cites work | Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database | Q84121735 |
| Evidence-based urology in practice: likelihood ratios | Q84398169 | ||
| Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction | Q85114789 | ||
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer | Q33672510 | ||
| Performance of common genetic variants in breast-cancer risk models | Q34064069 | ||
| Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese | Q34447165 | ||
| Predicting prostate cancer risk through incorporation of prostate cancer gene 3. | Q34809531 | ||
| Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) | Q35868793 | ||
| Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone | Q35924515 | ||
| Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers | Q36097440 | ||
| Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial | Q36599573 | ||
| Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. | Q36739758 | ||
| Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q36858843 | ||
| Updating risk prediction tools: a case study in prostate cancer | Q37025404 | ||
| External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. | Q37074118 | ||
| A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk | Q37217578 | ||
| Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model | Q37246495 | ||
| External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population | Q39778617 | ||
| Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection | Q39904254 | ||
| Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort | Q39939334 | ||
| Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3. | Q39954842 | ||
| Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population? | Q40087634 | ||
| Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol. | Q40093970 | ||
| Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population. | Q42932905 | ||
| The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies | Q44250334 | ||
| Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project | Q44506470 | ||
| Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study. | Q54387343 | ||
| Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators | Q57941019 | ||
| Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort | Q62778214 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sweden | Q34 |
| database | Q8513 | ||
| P304 | page(s) | 460-465 | |
| P577 | publication date | 2014-09-19 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Incorporation of detailed family history from the Swedish Family Cancer Database into the PCPT risk calculator | |
| P478 | volume | 193 |
| Q97067005 | A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort |
| Q104078931 | Diagnostic molecular markers predicting aggressive potential in low-grade prostate cancer |
| Q50107743 | Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator |
| Q47600543 | Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy. |
| Q52624230 | Prostate cancer screening-when to start and how to screen? |
Search more.